MASI vs GMED

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 13, 2026

MASI

60.4
AI Score
VS
MASI Wins

GMED

51.1
AI Score

Investment Advisor Scores

MASI

60score
Recommendation
BUY

GMED

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric MASI GMED Winner
Forward P/E 40.8163 16.7785 GMED
PEG Ratio 4.8334 1.7253 GMED
Revenue Growth 8.5% 27.0% GMED
Earnings Growth 214.4% 66.7% MASI
Tradestie Score 60.4/100 51.1/100 MASI
Profit Margin 4.9% 18.9% GMED
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD MASI

Frequently Asked Questions

Based on our detailed analysis, MASI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.